These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 8135876)

  • 21. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y; Tani T; Kanbe T; Watanabe K
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein II/III antagonist.
    Hoffmann P; Bernat A; Savi P; Herbert JM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):670-5. PubMed ID: 9694919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
    Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
    Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dipfluzine on platelet aggregation and thrombus formation.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):443-6. PubMed ID: 7717072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
    Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
    Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
    Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
    Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism.
    Wang YY; Tang ZY; Dong M; Liu XY; Peng SQ
    Acta Pharmacol Sin; 2004 Apr; 25(4):469-73. PubMed ID: 15066215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
    Xu HL; Feng YP
    Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
    Ting HJ; Khasawneh FT
    Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H; Williams P
    J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antithrombotic action of benzydamine].
    Jansen JW
    Arzneimittelforschung; 1987 May; 37(5A):626-8. PubMed ID: 3619983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
    Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
    Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
    Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
    J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent.
    Molinari A; Guarneri L; Pacei E; de Marchi F; Cerletti C; de Gaetano G
    J Pharmacol Exp Ther; 1987 Feb; 240(2):623-7. PubMed ID: 3806414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
    Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
    Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of subacute treatment with benzopyranopyrimidines in hemostasis and experimental thrombosis in mice.
    Ballabeni V; Calcina F; Tognolini M; Bruno O; Manotti C; Barocelli E
    Life Sci; 2004 Feb; 74(15):1851-9. PubMed ID: 14761666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.